Home › Urothelial (Transitional Cell) Carcinoma › Washington › Seattle
Pag-aaral pangklinika para sa Urothelial (Transitional Cell) Carcinoma sa Seattle, WA
Isang pag-aaral para sa Urothelial (Transitional Cell) Carcinoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Seattle. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Nagre-recruitPhase 3
- Fred Hutchinson Cancer Center, Seattle
- FHCC at Northwest Hospital, Seattle
- University of Washington Medical Center - Montlake, Seattle
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Nagre-recruitPhase 1/2
- Eye Associates Northwest - Ballard Clinic and Surgery Center, Seattle
- Eye Associates Northwest - First Hill Clinic, Seattle
- Harborview Medical Center, Seattle
- at 3 pa
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Nagre-recruitPhase 1
- Swedish Cancer Institute, Seattle
A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial
Nagre-recruit
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Nagre-recruitPhase 2
- Harborview Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
Nagre-recruitPhase 3
- Research Site, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Seattle
A Study of NX-1607 in Adults With Advanced Malignancies
Nagre-recruitPhase 1
- Fred Hutchinson Cancer Center, Seattle
Pag-aaral para sa Urothelial (Transitional Cell) Carcinoma sa ibang lungsod
- Nashville, TN23 pag-aaral
- New York City, NY22 pag-aaral
- Houston, TX19 pag-aaral
- Dallas, TX18 pag-aaral
- Edison, NJ18 pag-aaral
- Los Angeles, CA17 pag-aaral
- Queens, NY15 pag-aaral
- Chicago, IL14 pag-aaral
- Arlington, VA12 pag-aaral
- Boston, MA11 pag-aaral
- San Antonio, TX11 pag-aaral
- Austin, TX10 pag-aaral
Iba pang pag-aaral sa Seattle
- Non-Small Cell Lung Cancer53 pag-aaral
- Kanser (lahat ng uri)49 pag-aaral
- Kanser sa Prostate42 pag-aaral
- Acute Myeloid Leukemia41 pag-aaral
- Kanser sa Suso39 pag-aaral
- Metastatic Cancer39 pag-aaral
- Colorectal Cancer34 pag-aaral
- Kanser sa Baga33 pag-aaral
- Kanser sa Ovary30 pag-aaral
- Multiple Myeloma22 pag-aaral
- Kanser sa Pantog21 pag-aaral
- Myelodysplastic Syndromes21 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.